Search

Learn about the aspiring scientists who were celebrated this month for completing a unique summer research program.

… Tuesday, August 28, 2018 Nineteen aspiring scientists were celebrated this month for completing a unique summer research program offered by the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences . Four of the students received special recognition for their outstanding performance and

MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer.

… Wednesday, July 22, 2020 Summary MSK’s sarcoma team is focused on developing new treatments for sarcoma, a rare group of cancers that affect the body’s connective tissues. As one of the world’s most respected comprehensive centers devoted exclusively to cancer, Memorial Sloan Kettering has entire teams

MSK scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments.

… Thursday, January 4, 2018 Summary The breakneck speed at which cancer research and treatment is progressing is driven in large part by critical advances in technology. Our scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments. Here,

In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.

… Friday, February 1, 2002 Improves Ability to Make Treatment Decisions In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available

Learn about MSK's specialty in treating neuroendocrine cancers.

… Friday, March 7, 2025 The good news is that treatments for prostate cancer are helping patients live longer. But an unsettling new challenge is emerging: a different and deadlier form of the cancer called neuroendocrine prostate cancer (NEPC). Researchers at Memorial Sloan Kettering Cancer Center (MSK

A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.

… Thursday, December 11, 2025 A powerful treatment is now an option for many more people with  bladder cancer , the fifth most common form of cancer. The U.S. Food and Drug Administration (FDA) on November 21 approved a combination of two drugs —  enfortumab vedotin (Padcev®)  and an immunotherapy drug

Learn about MSK’s Adolescent and Young Adult program, which is uniquely positioned to help patients like Danielle Leventhal.

… Thursday, October 1, 2020 Tyler Wong’s girlfriend first sensed something was off. In April 2020, the couple was cuddling at home when girlfriend Joanhy felt a lump in Tyler’s belly. Tyler felt it too. Thinking it could be a hernia, Joanhy asked the urologist she works for to examine Tyler. The doctor

For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue. 

… Tuesday, April 15, 2025 Treating liver cancer and liver metastases — cancer that has spread to the liver from elsewhere in the body — is challenging. Most patients are not candidates for surgery because there are many tumors or because the tumors are in difficult locations.   In some cases, however,

The multicenter project, which yielded dozens of scientific papers on more than 30 different kinds of cancer, has officially drawn to a close.

… Friday, January 4, 2019 Summary This wide-ranging effort, which was jointly funded by the National Human Genome Research Institute and the National Cancer Institute, has been completed. When The Cancer Genome Atlas (TCGA) launched in 2005, the understanding of the genetic changes that drive cancer was

Experts from Memorial Sloan Kettering presented some of the latest research on this challenging complication of many cancer surgeries.

… Friday, December 7, 2018 Summary Cancer-related lymphedema is one of the most challenging long-term side effects that can occur after cancer surgery. It can greatly impact a person’s quality of life. Cancer-related lymphedema is one of the most challenging long-term side effects that can occur after